ZEVALIN IBRITUMOMAB TIUXETAN NUCLEAR PHARMACEUTICAL
Published: 05/12/2010
Description
Issue Date: 5/11/2010 Contract Number: Q 09 - 353 Zevalin Ibritumomab Tiuxetan Nuclear Pharmaceutical Description: Stony Brook University Medical Center intends to make a purchase of Ibritumomab Tiuxetan, trade name Zevalin and related supplies pursu...
